Atlas Trials

Optimized Antiplatelet Therapy on the Prognosis of ACS Patients With Non-predominant Coronary Artery Disease After PCI

Clinical trial NCT04338919 · UNKNOWN

Trial details

NCT number
NCT04338919
Sponsor
Fujian Medical University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Acute Coronary SyndromePercutaneous Coronary Intervention
Start date
2020-04-14
Primary completion
2021-04-01
Enrollment
2020

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.